Listed

XTL Biopharmaceuticals Ltd: Form 6-K, filed May 22, 2018

Filed with the SEC on May 22, 2018 and accepted by EDGAR at May 22, 2018, 14:49 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001213900-18-006707. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.